Key Developments in CDK4/6 Inhibitors for Breast Cancer: Transforming Treatment Landscape in 2024
The landscape of breast cancer treatment has been significantly altered in recent years, with one of the most promising advancements being the development of CDK4/6 inhibitors. These drugs are reshaping … Read More